Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_assertion description "[Here, treatment with the novel LSD1 antagonist SP2509 attenuated the binding of LSD1 with the corepressor CoREST, increased the permissive H3K4Me3 mark on the target gene promoters, and increased the levels of p21, p27 and CCAAT/enhancer binding protein ? in cultured AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_assertion evidence source_evidence_literature NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_assertion SIO_000772 24699304 NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_assertion wasDerivedFrom befree-2016 NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_assertion wasGeneratedBy ECO_0000203 NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1170043.RAtjxQwECP63pzCqebASIRDrbcdPcII2Mt8l45p0UGHHQ130_provenance.